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Primary congenital glaucoma (PCG) is an autosomal-recessive condition characterized by high intraocular pressure (IOP), usually within
the ﬁrst year of life, which potentially could lead to optic nerve damage, globe enlargement, and permanent loss of vision. To date, PCG
has been linked to three loci: 2p21 (GLC3A), for which the responsible gene is CYP1B1, and 1p36 (GLC3B) and 14q24 (GLC3C), for
which the genes remain to be identiﬁed. Here we report that null mutations in LTBP2 cause PCG in four consanguineous families
from Pakistan and in patients of Gypsy ethnicity. LTBP2 maps to chromosome 14q24.3 but is around 1.3 Mb proximal to the docu-
mented GLC3C locus. Therefore, it remains to be determined whether LTBP2 is the GLC3C gene or whether a second adjacent gene
is also implicated in PCG. LTBP2 is the largestmember of the latent transforming growth factor (TGF)-beta binding protein family, which
are extracellular matrix proteins with multidomain structure. It has homology to ﬁbrillins and may have roles in cell adhesion and as
a structural component of microﬁbrils. We conﬁrmed localization of LTBP2 in the anterior segment of the eye, at the ciliary body,
and particularly the ciliary process. These ﬁndings reveal that LTBP2 is essential for normal development of the anterior chamber of
the eye, where it may have a structural role in maintaining ciliary muscle tone.Primary congenital glaucoma (PCG) is a relatively rare
cause of glaucoma that usually manifests within the ﬁrst
year of life. It is characterized by high intraocular pressure
(IOP) resulting from an obstruction of aqueous outﬂow
from the anterior segment of the eye, thought to be the
result of an anomaly of the trabecular meshwork and ante-
rior chamber angle.1,2 Increased IOP causes irreversible
damage to the optic nerve and can lead to blindness if
untreated. Affected children typically present with tearing,
photophobia, corneal clouding, and enlargement of the
globe or cornea.3
In most families, PCG is inherited as an autosomal-reces-
sive condition, and it is more common in communities in
which the rate of consanguinity is high. Its prevalence
varies from ~1:10,000 in Western countries4 to ~1:3,300
in Southern India,5 ~1:2,500 in Saudi Arabia,6 and
~1:1,250 in the Gypsy subpopulation of Slovakia.7 Three
loci for PCG have been reported: GLC3A (2p21 [MIM
#231300]),8 GLC3B (1p36 [MIM %600975]),9 and GLC3C
(14q24, I.R. Stoilov and M. Sarfarazi, 2002, A.R.V.O.,
abstract; A. Booth et al., 2008, A.R.V.O., abstract).10 Muta-
tions in Cytochrome P4501B1 (CYP1B1 [MIM *601771]) at
the GLC3A locus account for up to 50% of cases11,12 and
more than 100 CYP1B1 mutations have been reported in
the Human Gene Mutation Database. No responsible
gene has yet been identiﬁed at the GLC3B and GLC3C664 The American Journal of Human Genetics 84, 664–671, May 15,loci. The purpose of the current study was to identify the
mutated gene in families with PCG that do not map to
the CYP1B1 locus.
Previously, we described three unrelated consanguin-
eous Pakistani PCG families, MEP47, PKGL005, and
PKGL025, in which homozygosity mapping and linkage
analysis implicated a gene within or close to GLC3C on
chromosome 14q24 (A. Booth et al., 2008, A.R.V.O.,
abstract; Figure S1 available online).10 In addition, we as-
certained one further family, PKGL010, consistent with
GLC3C linkage (S.R., unpublished data). The study was
approved by a UK ethics committee and by the institu-
tional review board at the Centre of Excellence in Molec-
ular Biology, Pakistan. Informed consent was obtained
from participants and from the elders of each household.
Members of consenting families underwent ophthalmic
examination, which revealed that affected individuals
have typical PCG disease features (Figure 1).10 All the
patients had a history of tearing and photophobia from
either shortly after birth (for MEP47 and PKGL025) or
within the ﬁrst 3 years of life (for PKGL005 and
PKGL010). Most had undergone multiple, failed surgical
procedures without antimetabolite therapy and at the
time of examination had visual acuities of count ﬁngers
or worse. The clinical notes available recorded raised intra-
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Figure 1. Clinical Features of PCG
Patients
(A) For the MEP47 family, photos of the
anterior segment of the affected family
members are shown. At the time of exami-
nation, patients II.1, II.2, II.3, and II.4
were aged 42, 34, 26, and 24 years old,
respectively. Case II.1 has Haab’s striae
in the right eye and a central corneal scar
secondary to infection in the left eye.
Cases II.2, II.3 (right eye), and II.4 (right
eye) have corneal enlargement and cloud-
ing. The left eye of case II.4 has an
enlarged but clear cornea after surgery.
(B) Slit lamp examination of an affected
patient 25 aged 5 years old from family
PKGL025 shows dislocation of the lens
(ectopia lentis).(up to 56 mmHg), with corneal enlargement (horizontal
corneal diameter up to 15 mm) and clouding. Peripheral
blood was taken from each family member and genomic
DNA was extracted according to standard procedures.
Haplotype analysis in these families suggested that the
disease gene localizes to a ~4.2 Mb region, ﬂanked by the
markers D14S289 and D14S85, which contains 97 known
genes.10 Interestingly, this locus is immediately adjacent to
but does not overlap the documented GLC3C locus, ﬁrst
described in a family of Turkish origin, which lies in the
interval D14S61 to D14S1000 (I.R. Stoilov andM. Sarfarazi,
2002, A.R.V.O., abstract). Within the interval implicated in
the Pakistani families, we systematically viewed the infor-
mation on each gene with GeneCards and OMIM. The
candidate genes were prioritized based on the available
literature and their proposed suitability in eye function.
The latent transforming growth factor beta binding protein 2
gene (LTBP2 [MIM *602091]) was selected as a strong
candidate based on its distribution in the anterior segment
of the eye.13 The primer pairs used in the PCR ampliﬁca-
tions and sequencing are depicted in Table S1. Upon
sequencing LTBP2, we identiﬁed premature nonsense
mutations segregating with PCG in each family (Figures 2
and 3). In MEP47, a homozygous single base pair deletion
was identiﬁed in exon 1, causing a frameshift and putative
stop codon 140 amino acids downstream (c.412 delG;
p.A138PfsX278). The sequence variation was conﬁrmed
in family members on PCR-ampliﬁed DNA with the use
of primers 1BF and 1BR followed by SmaI restriction
enzyme digestion. In the patients, a SmaI site was de-
stroyed to give a 342 bp product instead of the 218 and
124 bp that would be expected for wild-type sequence. In
PKGL005, a homozygous single base change converts an
arginine residue to a premature stop codon in exon 4The Am(c.895C / T; p.R299X). This mutation was conﬁrmed
in family members on PCR-ampliﬁed DNAwith the primer
pairs 4IIF and 4R and digestion with the enzyme AlwNI. In
the patients, an AlwNI site was formed so that the 257 bp
PCR would be digested to yield 228 and 29 bp products. In
PKGL025, a homozygous 14 base pair deletion in exon 6
causes a frameshift and putative stop codon 181 amino
acids downstream (c.1243-1256 del; p.E415RfsX596). The
sequence variation was conﬁrmed in family members by
restriction digestions with BsmI on PCR-ampliﬁed DNA
with the use of primer pairs 6F and 6IIR. In the patients,
a BsmI site was destroyed to give a 372 bp product instead
of 245 and 141 bp after digestion. Finally, in PKGL010,
a homozygous single nucleotide substitution creates
a stop codon in exon 1 (c.331C/ T; p.Q111X). This muta-
tion was conﬁrmed in the DNA of family members after
PCR ampliﬁcation with 1BF and 1BIIR and digestion with
the restriction endonuclease, AlwNI. The mutation de-
stroyed a recognition site for this enzyme to give an intact
172 bp product instead of 143 and 29 bp as expected for
the wild-type sequence. These mutations segregated with
the PCG phenotype in each family and were excluded
from a panel of 110 ethnically matched control DNAs. It
is interesting to note that although the four Pakistani fami-
lies all originated from the Punjab province, they each
reside in different cities and also belong to different clans
(Table S2). The lack of a single founder mutation common
to two or more of these families is consistent with their
diverse geographical and ethnic origins.
In addition to investigating the role of LTBP2 in Pakis-
tani PCG families, we also looked in PCG cases from Euro-
pean Gypsies. It has been suggested that the European
Gypsies originated from a founder population of Indian
subcontinent extraction that migrated from India arounderican Journal of Human Genetics 84, 664–671, May 15, 2009 665
Figure 2. LTBP2 Genetic Analysis in PCG Affecteds
(A) Diagrammatic representation of the LTBP2 protein illustrating the position of the four mutations relative to the full-length 1821
amino acid protein. The domains in the protein are also shown; SP depicts the signal peptide, TB the transforming growth factor beta
binding protein-like motif, EGF-like and EGF-CA both represent epidermal growth factor-like domains but the latter also has a calcium
binding motif.
(B) Sequence chromatograms of a normal individual and one PCG-affected patient from each of the families. The sequences highlight the
mutation in (1) MEP47 (exon 1), (2) PKGL005 (exon 4), (3) PKGL025 (exon 6), and (4) PKGL010 (exon 1).1000 years ago14 and that the high prevalence of PCG in
this population7,15 may imply an unidentiﬁed ancestral
mutation. Recruitment, clinical diagnostic criteria, and
CYP1B1 gene investigations in the Gypsy samples were
approved by the human research ethics committee, the
University of Western Australia, and have been described
elsewhere.15 Analysis of LTBP2 in 15 CYP1B1-negative
Gypsy patients identiﬁed c.895C/ T; p.R299X, the muta-
tion segregating in Pakistani family PKGL005, in 8 of the
Gypsy cases. The examination of 14 intragenic LTBP2
single-nucleotide polymorphisms revealed an identical
haplotype shared between the affected members of the
PKGL005 family and the Gypsy PCG patients homozygous
for the p.R299Xmutation (Table 1), implying that they are
distantly related by a common ancestor. The Pakistani
PKGL005 family belongs to the Jatt (Jat), a clan/ethnic
group of Indo-Aryan descent proposed previously as
a possible Gypsy parental population.16 These ﬁndings
provide further support for this hypothesis and suggest
that p.R299X is an ancient founder mutation predating
the emergence of European Gypsies from the Jatt. Our
data also suggest that p.R299X in LTBP2 is the major
PCG founder mutation in the Gypsy population,
accounting for more than 50% of CYP1B1-negative and
nearly 40% of all PCG cases and is thus of considerable
diagnostic signiﬁcance.
The 35 exon LTBP2 gene encodes a 1821 amino acid
protein sequence that was analyzed for domains with the666 The American Journal of Human Genetics 84, 664–671, May 15SMART program and shown to consist of 20 epidermal
growth factor (EGF)-like domains, 4 transforming growth
factor beta binding protein (TB)-like modules each con-
taining 8 cysteine residues, and an amino-terminal signal
peptide (Figure 2A). Sixteen of the EGF domains have
calcium-binding motifs and it has been suggested that
these adopt a rod-like molecular arrangement upon
calcium binding in order to present a speciﬁc surface for
protein-protein interactions.17 The cysteine-containing
TB domains are unique features of the LTBP-ﬁbrillin super-
family, providing a degree of conformational ﬂexibility.18
LTBP2 has ~45% amino acid identity to LTBP1 and ~25%
identity to ﬁbrillin1, but unlike other LTBP family
members, LTBP2 has been reported not to bind to latent
forms of TGF-b.19 The secretory signal targets the protein
to the extracellular matrix, where it has cell-adhesive prop-
erties,20 a functional role as a docking molecule for elastic
ﬁber assembly,21 and a structural role as a component of
ﬁbrillin-rich microﬁbrils in connective tissues.22 The car-
boxy-terminal region of LTBP2 competes with LTBP1 for
speciﬁc binding to the amino-terminal region of ﬁbrillin1,
but not ﬁbrillin2, in microﬁbrils.23
Intriguingly, LTBP2 knockout mice die before embryonic
day 6.5.24 In situ hybridization analysis of mouse embryos
reveals a pattern of expression primarily restricted to carti-
lage perichondrium and blood vessels.25 In order to inves-
tigate the distribution of the corresponding protein in
mouse embryos, we stained serial sections with a rabbit, 2009
Figure 3. Segregation of the LTBP2 Mutation in Each of the Families
The pedigree structures and individual IDs are shown for MEP47 and PKGL010; however, only the families from which DNA is available are
shown for PKGL005 and PKGL025 because the full pedigrees have been published before.10 The agarose gel photographs depicted show
segregation of all four mutations with the disease phenotype in each of the respective families as would be expected for a recessive mode
of inheritance. Only the PCG-affected members have both LTBP2 alleles mutated as illustrated by the unique banding pattern on the
agarose gel. The banding pattern for CTL represents a wild-type control individual.polyclonal antiserum against cow LTBP2 (Figure 4). In
brief, whole mouse embryos at E15 were formalin ﬁxed
and embedded in parafﬁn according to standard methods.
4 mm serial sections were incubated either with rabbit poly-
clonal LTBP2 antibody (LifeSpan Biosciences Inc., Seattle,
WA) or the Rabbit Envision Detection system (DAKO,
Cambridge, UK). Bound primary antibody was detected
with the Rabbit Envision Detection system. The slides
were digitized by an Aperio Scanscope (Aperio Technolo-The Amgies Inc., CA) and examined with Imagescope Software
(Aperio). LTBP2 was shown to localize to the connective
tissues throughout the body and in particular the spinal
cord, cardiac, and skeletal muscles as well as the renal
and seminiferous tubules. In order to investigate whether
the widespread tissue localization may be due to crossreac-
tivity with other LTBP-ﬁbrillin family members, western
blot analysis of protein extracts was performed
(Figure S2). The antibody recognized a singleTable 1. Intragenic LTBP2 SNP Haplotypes
PCG Affecteds
PCR
Amplicon
Chr14 position
Ref_Assembly
Build 36.3 SNP ID Alleles MEP47 PKGL025 PKGL010 PKGL005
GYPSY p.R299X
homozygotes
GYPSY
non-p.R299X
Normal
European
1B 74147995 ss120037874 A/C C A A A A A A
4 74092085 PCG mutation
p.R299X
C/T C C C T T C C
6 74088910 rs11622992 A/G G A A G G A/G A/G
9 74072528 rs4899522 C/T C T C C C C C
14 74061712 rs862030 A/G A A G G G G A/G
14 74061608 rs862031 C/T C C C C C C C/T
14 74061494 rs862032 A/T T A A A A A A
15 74059186 rs699371 A/G G G G G G G A/G
15 74059179 ss120037875 C/G G G C C C G G
16 74058354 ss120037876 C/T C C C T T C C
18 74047763 ss120037877 C/G G C C C C C C
19 74046435 ss120037878 C/T T T T C C T T
25 74043493 rs3815329 C/T T T T C C C/T T
27 74042695 rs2286411 C/T T C T C C C/T C/T
The PCR amplicon (from Table S1) that was used to locate the SNP, its position in the UCSC genome browser, ID, and allelic variants are shown. Five novel
SNPs discovered during this work are shown with the submitter SNP ID (ss) numbers. Haplotypes were constructed based on 14 intragenic SNPs for the PCG
affecteds in families MEP47, PKGL025, PKGL010, PKGL005, Gypsies with a homozygous p.R299X mutation, and a Gypsy patient that does not have the
p.R299X mutation. The LTBP2 haplotype for a normal European that does not have PCG was also constructed as a control. Note that the PCG affecteds
in the family PKGL005 and Gypsies that are p.R299X homozygotes have identical haplotypes across the LTBP2 gene.erican Journal of Human Genetics 84, 664–671, May 15, 2009 667
Figure 4. Immunohistological Locali-
zation of LTBP2 in Mouse Embryonic
Tissue
Section of whole mouse embryo at E15
stained with (1) rabbit polyclonal LTBP2
antibody or (2) the Rabbit Envision Detec-
tion system as negative control. LTBP2
immunoreactivity depicted as brown stain-
ing was present in the connective tissues
throughout the body with an increased
localization in the spinal cord (i), the
cardiac muscle (ii), the skeletal muscle
(iii), and the renal and seminiferous
tubules (iv). Scale bars represent 500 mm.immunoreactive species of the expected size for LTBP2,
conﬁrming the speciﬁcity of the antiserum. These observa-
tions imply that LTBP2 has a wider structural role in the
body, and although this role may be partially fulﬁlled by
other related proteins in the PCG patients, a similar
compensatory mechanism does not exist or is not sufﬁ-
cient to sustain life beyond the embryonic stage in mice.
LTBP2 interacts with ﬁbrillin1, mutations in which
cause Marfan syndrome (MIM #154700).26 Interestingly,
as well as having skeletal and cardiovascular abnormalities,
Marfan patients often have ectopia lentis (either partial or
complete displacement of the lens) and patients can also
develop glaucoma by several different mechanisms.27,28
Furthermore, single-nucleotide polymorphisms in the
LTBP2 gene are signiﬁcantly associated with bone mineral
density variation and fracture risk.29 In light of these pub-
lished ﬁndings, we re-examined patients from the PCG
families PKGL005, PKGL010, and PKGL025 described
herein for signs of skeletal or other abnormalities (Table
S3). Bone mineral density was measured in a PCG-affected
member from each of these families via dual energy X-ray
absorbtiometry (DEXA). These results showed that the
PCG-affected individuals as well as the carriers showed
mild to moderate osteopenia. Clinical examination of the
PCG-affected members showed a high arched palate but
other features were not suggestive of classical Marfan
syndrome. The echocardiogram investigations were
normal in most cases apart from an affected member
(patient 10, aged 18 years) from family PKGL010, who
had a bicuspid aortic valve and minimal aortic stenosis.
Slit lamp examination, where possible, showed that several
affected members were aphakic (lens removed by previous
surgery), though it was not known whether this was
because of cataract formation or ectopia lentis. Two further
affected members (patient 25, aged 5 years and patient 28,
aged 2 years at the time of examination) from family
PKGL025 showed unilateral (Figure 1B) and bilateral ecto-
pia lentis. In MEP47, no history of recurrent fractures or
heart problems was reported, but all cases had a Marfanoid
habitus with arachnodactyly, joint hypermobility with
a positive Steinberg sign, tall stature, and an arm span668 The American Journal of Human Genetics 84, 664–671, May 15greater than height. DEXA scanning was not performed
in members of this family and corneal clouding made it
impossible to identify or exclude ectopia lentis given that
the examination was performed in the family home.
Whether the skeletal and cardiac features described are
related to the lack of functional LTBP2 in these patients
requires further investigation; however, ectopia lentis
could represent an additional ocular feature for this type
of glaucoma.
The precise mechanism by which mutations in LTBP2
lead to PCG is unknown. In order to investigate the distri-
bution of LTBP2 in the anterior segment structures of the
eye, sections of mouse and cow eyes were stained with
the rabbit polyclonal antiserum (Figure 5). For this, adult
mouse and cow eyes were either formalin ﬁxed and
parafﬁn embedded or cryopreserved according to standard
procedures. The parafﬁn-embedded sections (4 mm) were
incubated with hematoxylin and eosin, rabbit polyclonal
LTBP2 antibody, or the Rabbit Envision Detection system
and the slides were processed, digitized, and examined as
described before. The cryosections (6 mm) were incubated
with hematoxylin and eosin, anti-LTBP2, or a rabbit IgG
isotype negative control (Invitrogen Ltd., Paisley, UK).
Bound primary antibody was detected with Alexa Fluor
488 conjugated secondary antibody (Invitrogen) and the
nuclei were counterstained with DAPI (Invitrogen). Immu-
noﬂuorescence was analyzed with an Eclipse TE200-E
confocal microscope (Nikon Instruments Inc., NY). In
both mouse and cow eyes, LTBP2 localized to the ciliary
body and particularly the extracellular matrix proteins at
the ciliary process. These observations suggest that defects
in LTBP2 may increase the elasticity of ciliary body struc-
tures and cause changes in the structural support of the
surrounding tissues. The defect could be in Schlemm’s
canal, because its elasticity is thought to inﬂuence aqueous
outﬂow.30 Alternatively, a change in the elasticity of the
scleral spur might alter the architecture of the trabecular
meshwork, because processes from both the ciliary body
and the trabecular meshwork insert into the scleral
spur.31 Indeed, some glaucoma medications that increase
the outﬂow facility of the eye act by stimulating ciliary, 2009
Figure 5. Localization of LTBP2 in the Adult Eye
(A) (1) Formalin-fixed sections of adult mouse eyes stained with hematoxylin and eosin (i), anti-LTBP2 (ii), or the Rabbit Envision Detec-
tion system (iv). In (ii), LTBP2 immunoreactivity was observed as brown staining in several structures of the eye including the sclera,
retina, cornea, trabecular meshwork, and the ciliary body. The black intense pigment that extends from the retinal pigment epithelium
to the iris is melanin (in (i), (ii), and (iv)). Scale bars represent 500 mm. The area surrounding the ciliary body in (ii) has been magnified
and is shown in (iii). Note LTBP2 immunoreactivity particularly at the trabecular meshwork (TM), the ciliary body (CB), and the ciliary
process (CP). Scale bar represents 100 mm. (2) Cryopreserved sections of adult mouse eyes stained either with anti-LTBP2 or a rabbit IgG
isotype negative control. LTBP2 immunoreactivity depicted as green fluorescence was present in the trabecular meshwork (TM), the ciliary
body (CB), and particularly the ciliary process. Scale bars represent 50 mm.
(B) Cow eye histological section showing the cornea, iris, and ciliary body stained with hematoxylin and eosin. Scale bar represents
1500 mm. The lens dislocated during the sectioning and the adjacent alignment of the iris with the cornea in the panel is an artifact
of tissue preparation. Cryosections stained with anti-LTBP2 or rabbit IgG negative control are shown. Note that the green fluorescence
corresponding to LTBP2 immunoreactivity is abundant in the ciliary body (CB) (i) and particularly intense in the extracellular matrix
structures (ECM) at the ciliary process (ii). Scale bars represent 150 mm.muscle contraction against the scleral spur to increase the
distension of the trabecular meshwork.32
LTBP2 is the second gene implicated in PCG to date.
Alleles of the other known PCG gene, CYP1B1, have also
been associated with early-onset primary open angle glau-
coma (POAG [MIM #137760].33,34 POAG, sometimes
called chronic glaucoma, is the most common form of
glaucoma and can remain undiagnosed for many years
while the optic nerve slowly deteriorates.35 It is thought
to be a genetically complex trait with both environmental
and inherited components.36 Previous studies have sug-
gested possible loci for POAG37,38 and a quantitative trait
locus for IOP39 on chromosome 14q, though neither studyThe Amesuggested an association precisely to the LTBP2 region.
Furthermore, there are two reports in the literature of
cytogenetic studies that suggest a tentative link between
chromosome 14q and glaucoma.40,41 It would therefore
be interesting to investigate whether LTBP2 gene polymor-
phisms or mutations in LTBP2 could contribute to raised
IOP in POAG.
In summary, we have identiﬁed homozygous null muta-
tions in LTBP2 as a cause of PCG in human patients. These
ﬁndings might have implications for the clinical manage-
ment of childhood blindness and give new insights into
the formation of the anterior structures of the eye, suggest-
ing that LTBP2 may have an important structural role inrican Journal of Human Genetics 84, 664–671, May 15, 2009 669
maintaining the shape of the ciliary body and its
surrounding structures. This ﬁnding also highlights
LTBP2 as a candidate susceptibility gene for the more
common and therefore more clinically signiﬁcant form
of glaucoma, POAG.
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